RSS-Feed abonnieren
DOI: 10.1055/s-0032-1323626
Epidemiology of Hepatitis D
Publikationsverlauf
Publikationsdatum:
29. August 2012 (online)
![](https://www.thieme-connect.de/media/sld/201203/lookinside/thumbnails/10.1055-s-0032-1323626-1.jpg)
Abstract
Hepatitis D occurs worldwide. The major victims of the hepatitis D virus (HDV) are individuals carrying the hepatitis B surface antigen (HBsAg); around 5% of the HBsAg carriers in the world are infected also by HDV. With the implementation of a hepatitis B virus (HBV) vaccination since the 1990s, the incidence of hepatitis D has consistently declined in the developed world, particularly in Southern Europe; however, immigrants from areas where HDV remains endemic are reintroducing the infection.
Hepatitis D continues to ravage populations of developing and poor countries where HBV remains unchecked; action is needed to enforce HBV vaccination as effective prophylaxis not only against HBV, but against HDV as well.
-
References
- 1 Rizzetto M, Shih JW, Gerin JL. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol 1980; 125 (1) 318-324
- 2 Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980; 141 (5) 590-602
- 3 Rizzetto M. The delta agent. Hepatology 1983; 3 (5) 729-737
- 4 Rizzetto M, Bonino F, Verme G. Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis. Semin Liver Dis 1988; 8 (4) 350-356
- 5 Le Gal F, Gault E, Ripault MP , et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis 2006; 12 (9) 1447-1450
- 6 Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology 1997; 234 (1) 160-167
- 7 Le Gal F, Badur S, Hawajri NA , et al. Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Arch Virol 2012; 157 (4) 647-659
- 8 Esmaeli R, Alavian SM, Hajibeigi B , et al. Phylogenetic analysis of twenty-six cases of hepatitis delta virus isolates in Teheran, Iran. Hepat Mon 2009; 9 (3) 196-200
- 9 Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutierrez MF, Carrilho FJ, Pinho JR. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol 2011; 11 (6) 1462-1468
- 10 Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol 2003; 70 (1) 74-80
- 11 Wu JC, Huang IA, Huang YH, Chen JY, Sheen IJ. Mixed genotypes infection with hepatitis D virus. J Med Virol 1999; 57 (1) 64-67
- 12 Barros LM, Gomes-Gouvêa MS, Pinho JR , et al. Hepatitis delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves?. Virus Res 2011; 160 (1–2) 333-339
- 13 Kiesslich D, Crispim MA, Santos C , et al. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. J Infect Dis 2009; 199 (11) 1608-1611
- 14 Su CW, Huang YH, Huo TI , et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006; 130 (6) 1625-1635
- 15 Watanabe H, Nagayama K, Enomoto N , et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol 2003; 84 (Pt 12) 3275-3289
- 16 Gomes-Gouvêa MS, Soares MC, Bensabath G , et al. Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region. J Gen Virol 2009; 90 (Pt 11) 2638-2643
- 17 Rizzetto M, Ponzetto A, Forzani I. Hepatitis delta virus as a global health problem. Vaccine 1990; 8 (Suppl) S10-S14 , discussion S21–S23
- 18 Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7 (1) 31-40
- 19 Rizzetto M, Hadziyannis S, Hannson B, Toukan A, Gust I. Hepatitis delta virus infection in the world: epidemiologic patterns and clinical expression. Gastroenterology International 1992; 5: 18-32
- 20 Ponzetto A, Negro F, Popper H , et al. Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees. Hepatology 1988; 8 (6) 1655-1661
- 21 Abbas Z, Jafri W, Raza S. Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol 2010; 16 (5) 554-562
- 22 Tamura I, Ichimura H, Koda T, Katayama S, Kurimura O, Kurimura T. Hepatitis delta virus infection in different time periods in Japan. J Gastroenterol Hepatol 1990; 5 (4) 407-410
- 23 Arakawa Y, Moriyama M, Taira M , et al. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepat 2000; 7 (5) 375-381
- 24 Jeong SH, Kim JM, Ahn HJ , et al. [The prevalence and clinical characteristics of hepatitis-delta infection in Korea]. Korean J Hepatol 2005; 11 (1) 43-50 , PMID 15788884
- 25 Kim HS, Kim SJ, Park HW , et al. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol 2011; 83 (7) 1172-1177
- 26 Echevarría JM, León P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 2003; 19 (6) 1583-1591
- 27 Sagnelli E, Stroffolini T, Ascione A , et al; Promoting Group. The epidemiology of hepatitis delta infection in Italy. J Hepatol 1992; 15 (1-2) 211-215
- 28 Tsai JF, Margolis HS, Fields HA, Chang WY, Tsai JH. Hepatitis delta virus superinfection among patients with chronic hepatitis B in southern Taiwan. Scand J Infect Dis 1990; 22 (4) 403-405
- 29 Hsu HM, Wang YF, Lo SH , et al. Hepatitis D virus infection among intravenous drug abusers in Taiwan: analysis of risk factors and liver function tests. J Med Virol 1990; 31 (2) 76-81
- 30 Lee SD, Wang JY, Wu JC, Chiang YT, Tsai YT, Lo KJ. Hepatitis B and D virus infection among drug abusers in Taiwan. J Med Virol 1986; 20 (3) 247-252
- 31 Liaw YF, Chiu KW, Chu CM, Sheen IS, Huang MJ. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. J Infect Dis 1990; 162 (5) 1170-1172
- 32 Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995; 22 (6) 1656-1660
- 33 Wu JC, Wang YJ, Hwang SJ , et al. Hepatitis D virus infection among prostitutes in Taiwan. J Gastroenterol Hepatol 1993; 8 (4) 334-337
- 34 Centers for Disease Control (CDC). Delta hepatitis—Massachusetts. MMWR Morb Mortal Wkly Rep 1984; 33 (35) 493-494
- 35 Ponzetto A, Seeff LB, Buskell-Bales Z , et al. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology 1984; 4 (6) 1111-1115
- 36 Ponzetto A, Cohen BJ, Vandervelde EM, Mortimer PP. Delta agent in Britain. Lancet 1983; 2 (8359) 1141-1142
- 37 Ljunggren KE, Hansson BG. Fulminant delta hepatitis among Swedish drug addicts. Scand J Infect Dis 1986; 18 (5) 397-400
- 38 Shattock AG, Kelly MG, Fielding J, Arthurs Y. Epidemic hepatitis B with delta-antigenaemia among Dublin drug-abusers. Ir J Med Sci 1982; 151 (11) 334-338
- 39 Rizzetto M. Hepatitis D: thirty years after. J Hepatol 2009; 50 (5) 1043-1050
- 40 Buti M, Homs M, Rodriguez-Frias F , et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat 2011; 18 (6) 434-442
- 41 Değertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008; 28 (4) 494-498
- 42 Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 1997; 12 (11) 747-751
- 43 Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in Taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 2002; 40 (8) 3047-3049
- 44 Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB ; Italian Hospitals' Collaborating Group. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 2009; 81 (12) 1999-2006
- 45 Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat 2009; 16 (12) 883-894
- 46 Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection—not a vanishing disease in Europe!. Hepatology 2007; 45 (5) 1331-1332 , author reply 1332–1333
- 47 Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Häussinger D. Socioepidemiological data on hepatitis delta in a German university clinic—increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 2003; 41 (6) 523-526
- 48 Cross TJ, Rizzi P, Horner M , et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008; 80 (2) 277-282
- 49 Le Gal F, Castelneau C, Gault E , et al. Reply to Wedemeyer et al.: Hepatitis D virus infection. Not a vanishing disease in Europe!. Hepatology 2007; 45: 1332-1333
- 50 Manesis EK, Vourli G, Dalekos G , et al. Prevalence and clinical course of chronic hepatitis D (CHD) in Greece during the last 3 decades. Poster #127. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 51 Viana S, Paraná R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 2005; 73 (4) 808-814
- 52 Nunes HM, Monteiro MR, Soares MdoC. Prevalêncìa dos marcadores serológicos dos virus das hepatites B e D na area indigena Apyterewa do grupo. Parakanoä, Para Brasil. Cad Saude Publica 2007; 23 (11) 2756-2766
- 53 Duarte MC, Cardona N, Poblete F , et al. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela. Trop Med Int Health 2010; 15 (8) 924-933
- 54 Alvarado-Mora MV, Fernandez MF, Gomes-Gouvêa MS, de Azevedo Neto RS, Carrilho FJ, Pinho JR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population—how is the epidemiological situation?. PLoS ONE 2011; 6 (4) e18888
- 55 Mendes-Correa MC, Gomes-Gouvêa MS, Alvarado-Mora MV , et al. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?. Int J Infect Dis 2011; 15 (12) e828-e832
- 56 Galizzi F J, Teixeira R, Fonseca JC, Souto FJ. Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units. Hepatol Int 2010; 4 (2) 511-515
- 57 Manesis EK. Epidemiology of hepatitis D viral infection. Paper presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 58 Chlabicz S, Grzeszczuk A, Lapiński TW, Prokopowicz D, Panasiuk A. Search for hepatitis delta virus (HDV) infection in hepatitis C patients in north-eastern Poland. Comparison with anti-HDV prevalence in chronic hepatitis B. Eur J Epidemiol 2003; 18 (6) 559-561
- 59 Ho E, Deltenre P, Nkuize M , et al. Hepatitis B-delta virus co-infection in Belgium: retrospective and prospective data and comparison to HBV monoinfection. Poster #104–105. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 60 Mihaljevic I, Lovric M, Stojic Vidovic M, Balia M, Jukic I. Seroprevalence of HDV in the population of HBsAg positive blood donors and patients tested in Croatian Institute of transfusion Medicine 2002–2010. Poster #130. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 61 Dimitrova NZ, Zhelev DIvanova, Antonov K, Mateva L. Clinical and virological characteristics of Bulgarian patients with chronic hepatitis D. Poster #82. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 62 Genné D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly 2011; 141: w13176 10.4414/smw.2011.13176
- 63 Krekulowa L, Rehak V. HDV genotype 1 newly identified in population of injecting drug users in Prague, Czech Republic. Poster #117. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 64 Kucirka LM, Farzadegan H, Feld JJ , et al. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis 2010; 202 (6) 845-852
- 65 Gish RG, Yi DH, Baqai SF, Mangahas MM, Clark MD, Kane SD. Characteristics of hepatitis delta in Northern California. Poster #94. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 66 Soriano V, Grint D, d'Arminio Monforte A , et al. Hepatitis delta in HIV-infected individuals in Europe. AIDS 2011; 25 (16) 1987-1992
- 67 Flodgren E, Bengtsson S, Knutsson M , et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 2000; 38 (9) 3311-3316
- 68 Børresen ML, Olsen OR, Ladefoged K , et al. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland. J Viral Hepat 2010; 17 (3) 162-170
- 69 Tsatsralt-Od B, Takahashi M, Endo K , et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia. J Med Virol 2006; 78 (5) 542-550
- 70 Davaalkham D, Ojima T, Uehara R , et al. Hepatitis delta virus infection in Mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg 2006; 75 (2) 365-369
- 71 Shaikh MA, Shaikh WM, Solangi GA, Shaikh BA, Soomro MA. Frequency of hepatitis D virus infection in hepatitis B surface antigen-positive liver diseases. J Coll Physicians Surg Pak 2011; 21 (1) 23-25
- 72 Zaidi G, Idrees M, Malik FA , et al. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Virol J 2010; 7: 283
- 73 Baig S, Siddiqui AA, Ahmed WU, Qureshi H, Arif A. Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders. J Coll Physicians Surg Pak 2009; 19 (11) 699-703
- 74 Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol 2007; 13 (18) 2604-2607
- 75 Mumtaz K, Hamid SS, Adil S , et al. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol 2005; 20 (10) 1503-1507
- 76 Makuwa M, Mintsa-Ndong A, Souquière S, Nkoghé D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J Clin Microbiol 2009; 47 (7) 2265-2268
- 77 Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R. High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon. J Clin Microbiol 2011; 49 (3) 1162-1164
- 78 Khan A, Kurbanov F, Tanaka Y , et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol 2008; 80 (2) 268-276
- 79 Nwokediuko SC, Ijeoma U. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. Niger J Clin Pract 2009; 12 (4) 439-442
- 80 Mansour W, Malick Z, Sidiya A , et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritana. J Med Virol 2012; 84 (8) 1186-1198
- 81 Rezvan H, Forouzandeh B, Taroyan S, Fadaiee S, Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection 1990; 18 (1) 26-28
- 82 Mohammad Alizadeh AH, Ranjbar M, Tehrani AS , et al. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran. J Microbiol Immunol Infect 2010; 43 (6) 519-523
- 83 Roshandel G, Semnani S, Abdolahi N , et al. Prevalence of hepatitis D virus infection in HBsAg positive subjects in Iran. Pak J Biol Sci 2007; 10 (10) 1751-1754
- 84 Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei-Andabili SH. Clinical features and seroepidemiology of anti-HDV antibody in patients with chronic hepatitis B virus infection in Iran: A meta-analysis. Hepat Mon 2011; 11: 960-967
- 85 Torabi S, Ebrahim-Poor S, Maljaie H, Naqili B. Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran. Urmia Med J 2002; 13: 290-297
- 86 Somi MH, Farhang S, Miri SM, Pouri AA, Mjidi G, Alavian SM. The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate?. Trop Doct 2009; 39 (3) 154-156
- 87 Zahedi MJ. Serologic prevalence of hepatitis D in HBsAg positive patients in Kerman, South of Iran. Kerman, Iran: Kerman University of Medical Sciences and Health Services; 2003
- 88 Parepa IR, Suceveanu AI, Suceveanu A, Mazilu L, Voinea F. Trends in epidemiology of hepatitis D virus infection among institutionalized children in Southeast Romania. Poster #140. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 89 Voiculescu M, Iliescu L, Ionescu C , et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis 2010; 19 (1) 43-48
- 90 Kondili LA, Cuko L, Chionne P , et al. Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years. Eur J Gastroenterol Hepatol 2010; 22 (2) 167-171
- 91 Sadiku E, Basho J. Hepatitis delta virus in Albania. Poster #145. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 92 Quaglio G, Ramadani N, Pattaro C , et al. Prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol 2008; 80 (5) 833-840
- 93 Bayan K, Yilmaz S, Tuzun Y, Yildirim Y. Epidemiological and clinical aspects of liver cirrhosis in adult patients living in Southeastern Anatolia: leading role of HBV in 505 cases. Hepatogastroenterology 2007; 54 (80) 2198-2202
- 94 Bahcecioglu IH, Aygun C, Gozel N, Poyrazoglu OK, Bulut Y, Yalniz M. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider. J Viral Hepat 2011; 18 (7) 518-524
- 95 Farci P, Burroughs AK, Thomas HC, Shamma'a M. Delta hepatitis in Lebanon. Prevalence studies and a report on six siblings with chronic delta-positive active hepatitis. J Hepatol 1987; 4 (2) 224-228
- 96 Ramia S, El-Zaatari M, Sharara AI, Ramlawi F, Farhat B. Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon. Epidemiol Infect 2007; 135 (6) 959-962
- 97 Djebbi A, Rebai WK, Bahri O, Hogga N, Sadraoui A, Triki H. [Serological markers, viral RNA and genotype of hepatitis delta virus in HBs antigen positive Tunisian patients]. Pathol Biol (Paris) 2009; 57 (7-8) 518-523
- 98 el Zayadi A, Ponzetto A, Selim O, Forzani B, Lavarini C, Rizzetto M. Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. Hepatogastroenterology 1988; 35 (6) 313-315
- 99 Morcos MM, Mikhail TH, Hanna WM, Abdel-Fattah S, el-Rasad MM, Wassef EL. The prevalence of delta virus infection in chronic liver disease in Egyptian children in comparison with some other countries. Panminerva Med 2000; 42 (2) 97-100
- 100 Elhaasi AF, Elzouki Y, Arabi B, Tobgi R. Prevalence of delta virus infection in patients with hepatitis B virus infection. Poster #87. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 101 Al-Traif I, Ali A, Dafalla M, Al-Tamimi W, Qassem L. Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia. Ann Saudi Med 2004; 24 (5) 343-344
- 102 Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis D in EMRO region: systematic review and meta-analysis. Hepat Mon, in press.
- 103 Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol 2007; 22 (12) 2093-2100
- 104 Viksna L, Krumina A, Shangirejeva A, Arsha F, Sondore V. Epidemiological and clinical aspects of delta virus infection patients in Latvia. Poster #118. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 105 Kamilov F, Musabaev Aliev B, Akhmedov U, Usmanova G, Fayzullaev H. Occult HDV infection. Poster #113. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 106 Ilyassova BS, Isatullaev EA, Nersesov AV. Arystanova. The serum levels of inflammatory cytokins in liver cirrhosis caused HBV and HDV infection. Poster #107. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 107 Nersesov AV, Izatullayev YA, Palgova LK , et al. Clinical peculiarities of HDV-infection in Kazakhstan. Poster #133. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 108 Otunbayeva J, Isina G, Bazhikova A. Profile of HBV-infection with delta hepatitis among the patients in Kazakhstan. “Vek clinics” medical center, obstetrics center of the MH of Kazakhstan. Poster #137. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 109 Ghazinyan HI, Asoyan AV, Shahapuni AR, Melik-Andreasyan GG. Clinical and epidemiological distribution of hepatitis delta. Poster #91. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 110 Kozhanova TV, Klushkina VV, Isaeva OV , et al. Prevalence of hepatitis delta virus infection in Tyva Republic, Russian Federation. Poster #119. Poster presented at: EASL Monothematic Conference Delta Hepatitis; September 24–26, 2010; Istanbul, Turkey. Available at: http://www2.kenes.com/ISTANBUL2010/SCIENTIFIC/Pages/Interactive_Scientific_Programme.aspx . Accessed May 21, 2012
- 111 Tulisov A, McMahon BJ, Koch A , et al. Viral hepatitis in the Arctic. A review from a circumpolar workshop on viral hepatitis, ICCH13. Alaska Med 2007; 49 (2, Suppl) 193-203
- 112 Cheng HH, Wang DQ, Minuk GY, Anand CM, Stowe TC, Buchan KA. The prevalence of antibody to delta virus in western Canada. Clin Invest Med 1986; 9 (3) 156-159
- 113 Rex KF, Krarup HB, Laurberg P, Andersen S. Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland. Scand J Gastroenterol 2012; 47 (6) 692-701
- 114 Narang A, Gupta P, Kar P, Chakravarty A. A prospective study of delta infection in fulminant hepatic failure. J Assoc Physicians India 1996; 44 (4) 246-247
- 115 Bhattacharyya S, Dalal BS, Lahiri A. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta. Indian J Public Health 1998; 42 (4) 108-112
- 116 Chakraborty P, Kailash U, Jain A , et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. Indian J Med Res 2005; 122 (3) 254-257
- 117 Saravanan S, Velu V, Kumarasamy N , et al. Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India. Trans R Soc Trop Med Hyg 2008; 102 (8) 793-796
- 118 Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India 2006; 19 (4) 203-217
- 119 Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. Trans R Soc Trop Med Hyg 2005; 99 (7) 483-484
- 120 Ciancio A, Rizzetto M. Clinical patterns, epidemiology and disease burden of hepatitis D virus chronic liver disease. In: Margolis H, Alter M, Liang T, Dienstag J, , eds. 10th International Symposium on Viral Hepatitis and Liver Disease. London: International Medical Press; 2002: 271-275
- 121 Li J, Wang J, Tian K, Wang Y, Zhang L, Huang H. Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J Huazhong Univ Sci Technolog Med Sci 2006; 26 (2) 221-224